Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Study objective is to evaluate the level of control of hypercholesterolemia in Egypt in patients taking lipid lowering agents for at least 3 months ( with no drug change or dose amendment for a minimum of 6 weeks).
Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Inclusion Criteria:
Exclusion Criteria: